FDA Approves Moderna's First mRNA Flu Vaccine for Older Adults

The U.S. Food and Drug Administration (FDA) has approved Moderna's first mRNA flu vaccine, specifically for use in older adults.

6 Aug, 02:24 — 6 Aug, 06:44

Post Share

Why this matters

This approval marks a significant advancement in vaccine technology, bringing mRNA technology, previously used for COVID-19, to seasonal flu prevention. It offers a new option for older adults, a demographic particularly vulnerable to severe flu complications, and could pave the way for more mRNA-based vaccines.

Key entitiesFDA Moderna Trump administration

The Story

What 4 sources agree on, dispute, and miss

What sources agree on

The FDA has approved Moderna's first mRNA flu vaccine
The vaccine is approved for adults aged 50 and older
The FDA initially refused to review Moderna's application for the vaccine

Key claims2 agreed · 1 unverified

✓

The FDA faced backlash for refusing to review Moderna's flu shot application.

agreed·forbesNYT

✓

The FDA reversed its initial refusal to review the application after a public outcry.

agreed·NYTforbes

The Trump administration was initially reluctant regarding the vaccine.

unverified·le-figaro

Coverage gaps

Mention of the Trump administration's initial reluctance regarding the vaccine

Reportedle-figaro

MissingforbesNYT

The Story

Analyzing sources…

Source Diversity

High (68/100)

4 sources30/33

Spectrum spread— 4/5 buckets covered25/33

Far L1

Far Left (1)

NYT

Left1

Left (1)

hvg

Center1

Center (1)

forbes

Right1

Right (1)

le-figaro

Far R

Geographic diversity— 3 regions13/34

US2Hungary1France1

Political spectrum

LeftCenterRight

nytimes

forbes

le-figaro

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

NYTcenter-leftcenter-leftanalyticalMostly FactualEmphasizes public outcry leading to FDA reversal

forbescentercenterneutral—Focuses on factual reporting of approval and prior refusal

le-figarocenter-rightcenter-rightneutral—Mentions Trump administration's initial reluctance

Coverage leans: center-left

The coverage generally presents the FDA's approval as a positive development, with some outlets highlighting the agency's initial reluctance and subsequent reversal.

Sources

Showing 2 of 4 sources

NYTMostly Factual6h ago

F.D.A. Approves Moderna’s mRNA Flu Vaccine

The agency had initially refused to even review the application but reversed course after a public outcry.

By Christina Jewett

Read full article →

forbes2h ago

FDA Approves First MRNA Flu Vaccine For Older Adults

The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.

By Siladitya Ray, Forbes Staff

Read full article →

Coverage Timeline

First report: NYT · 6 Aug, 02:24|Full coverage: 4 · 6h|Window: 6h

Left-leaningCenterRight-leaning

NYT6 Aug, 02:24First to report

F.D.A. Approves Moderna’s mRNA Flu Vaccine

3h later

le-figaro6 Aug, 05:22

Vaccin contre la grippe : Moderna obtient l’aval de l’administration américaine pour son premier sérum à ARNm

1h later

forbes6 Aug, 06:44

FDA Approves First MRNA Flu Vaccine For Older Adults

1h later

hvg6 Aug, 08:03Latest update

Rábólintott a hatóság, kezdődhet az influenza elleni mRNS-oltás használata

Story evolution

The narrative shifted from the FDA's initial resistance to its eventual approval, highlighting the impact of public pressure.

Initial FDA RefusalPrior to Aug 6

The FDA initially refused to review Moderna's application for its mRNA flu vaccine.

Public Outcry and ReversalPrior to Aug 6

Following public outcry, the FDA reversed its decision and proceeded with the review.

FDA ApprovalAug 6 morning

The FDA officially approved Moderna's mRNA flu vaccine for older adults.

PERSPECTA

PERSPECTA

FDA Approves Moderna's First mRNA Flu Vaccine for Older Adults

Why this matters

The Story

What sources agree on

Key claims2 agreed · 1 unverified

Coverage gaps

The Story

Source Diversity

Source Diversity

Political spectrum

Sources

F.D.A. Approves Moderna’s mRNA Flu Vaccine

FDA Approves First MRNA Flu Vaccine For Older Adults

Coverage Timeline

F.D.A. Approves Moderna’s mRNA Flu Vaccine

Vaccin contre la grippe : Moderna obtient l’aval de l’administration américaine pour son premier sérum à ARNm

FDA Approves First MRNA Flu Vaccine For Older Adults

Rábólintott a hatóság, kezdődhet az influenza elleni mRNS-oltás használata

Story evolution

Related Stories

Tips for Parents to Encourage Children to Drink More Water

Emergency Services in Niš Report Increased Collapses Due to High Temperatures

Study Links Birth Order to Health Risks: Firstborns More Prone to Autism, Lastborns to Substance Abuse

Surgeon Warns Against Fatal Appendicitis Misconceptions

PERSPECTA

Political spectrum

Why this matters

Story evolution

The Story

What sources agree on

Key claims2 agreed · 1 unverified

Coverage gaps

Coverage matrix